Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / EMHTF - These 4 Marijuana Stocks Could Surpass Investor Expectations


EMHTF - These 4 Marijuana Stocks Could Surpass Investor Expectations

CORAL GABLES, FL / ACCESSWIRE / February 4, 2019 / Marijuana stocks have managed to become one of the hottest topics in the news over the course of the past few years. The fact of the matter is that previously conceived notions on cannabis are being replaced by favorable public opinions supporting all possible uses of marijuana, namely as a means of treatment for patients suffering from a myriad of ailments. Following the recent passing of legislation in favor of legalizing cannabis, it is very likely that companies in the space will work even harder to develop innovative treatment options and products, designed with the consumer in mind. With the increase of capital and business entering the market, the cannabis sector has shown exciting promise in terms of opportunities for investors looking to space. Global Consortium Inc (GCGX), Emerald Health Therapeutics Inc (OTCQX: EMHTF) (TSX-V: EMH), Trulieve Cannabis Corp (OTC PINK: TCNNF), and OrganiGram Holdings Inc (OTCQX: OGRMF) are four pot stocks looking to remain on high this month.

Global Consortium Inc (GCGX) that you might not have heard of, but could definitely benefit from looking into. As the marijuana market has become increasingly more lucrative for some time now, Global Consortium is putting in the work to become one of the industry leaders in terms of hemp-derived CBD products. The company has maintained a focus that not only targets corporate growth but also tackles the public markets as well. Just before the end of the new year, the Company announced that it had rescinded their transactions with Trans Global Group, Inc. effective December 31, 2018.

As the Company takes the steps necessary to lead the CBD industry into the future, Global Consortium Inc (GCGX) has made it a point to build a corporate framework for these aspirations to be built upon. The Company today announced plans to design and build out America's first "Cannabis Mall." Per the details of the announcement, the Cannabis Mall, when completed, will house manufacturing, distribution, delivery, retail, and cultivation all under one 64,000 sure foot building.

Global Consortium Inc (GCGX) has stated that the distribution component of their "Cannabis Mall" will be leased out to a 3rd party with a 50% revenue share for Global, and all of Global's products will be distributed for free. The completion of the build out and final inspections are expected to be completed by April 1, 2019, at which time distribution will go operational.

For More Information On Global Consortium Inc, Click Here

Emerald Health Therapeutics Inc (EMHTF) (EMH) announced at the tail-end of last month that its joint venture partner, San Diego-based Emerald Health Bioceuticals, has launched its award-winning Endo products in Whole Foods Markets across the United States, highlighting the unique positioning and opportunity for this product line when it is launched in Canada in 2019. The joint venture, called Emerald Health Naturals, secured Canadian distribution rights for this product line that was developed to support the body's endocannabinoid system (ECS), but which does not contain cannabis. Canadian retailers have not been announced.

Gaetano Morello, CEO of Emerald Health, commented, "for the Endo products to be embraced by retailers with such high standards of retail excellence and broad reach like Whole Foods Market in the US is an important milestone for this unique natural health supplement line."

For More Information On Emerald Health Therapeutics Inc, Click Here

Trulieve Cannabis Corp (TCNNF) saw its shares enjoy a 6.10% boost in mid-afternoon trading on Monday, with shares trading at $12.53 per share. Towards the end of last month, the Company announced that it had been named the 2018 Diversity and Inclusion Champion of the Year by Minorities for Medical Marijuana. According to the announcement, the annual award acknowledges a leading cannabis organization for its leadership efforts in diversity and inclusion in two categories: Organizational Diversity and Inclusion and Market Outreach Strategies.

Following the announcement of the award, Kim Rivers, Trulieve's CEO, said, "we are incredibly honored to be the recipient of Minorities for Medical Marijuana's inaugural Diversity and Inclusion Champion of the Year Award."

For More Information On Trulieve Cannabis Corp, Click Here

OrganiGram Holdings Inc (OGRMF), the parent company of Organigram Inc, announced last week that the Company has surpassed the production of one million cannabis pre-rolls since the legalization of adult use recreational cannabis in October 2018. The Company credits the automation of its processes along with surging consumer demand for the success of its large-scale production.

In a press release regarding the milestone, Greg Engel, CEO, Organigram, said, "at Organigram, we are proud to be among a select group of licensed producers who have been able to rise to the challenge of large-scale pre-roll production. Our operations team has done an amazing job introducing automation to important parts of our process, building our overall capacity while retaining our focus on product quality."

For More Information On Organigram Holdings Inc, Click Here

About marijuanastocks.com

MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns www.MarijuanaStocks.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Global Consortium Inc. (GCGX), Midam has been paid $20,000 fromGlobal Consortium Inc. (GCGX) for a period from January 22, 2019 to February 22, 2019. We may buy or sell additional shares of (GCGX) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Global Consortium Inc. (GCGX). For previous compensation and disclaimer information, click here.

Contact Information:

pr@marijuanastocks.com

SOURCE: MarijuanaStocks.com

Stock Information

Company Name: Emerald Health Therapeutics
Stock Symbol: EMHTF
Market: OTC
Website: emeraldhealth.ca

Menu

EMHTF EMHTF Quote EMHTF Short EMHTF News EMHTF Articles EMHTF Message Board
Get EMHTF Alerts

News, Short Squeeze, Breakout and More Instantly...